Mycosis fungoides progression and chronic solvent exposure

Dermatology

Volumn 208, Issue 2, 2004, Pages 171-173

  Nikkels, Arjen F ^a   Quatresooz, Pascale ^a   Delvenne, Philippe ^a   Balsat, Alain ^a   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Interferon ; Mycosis fungoides; Occupational exposure; Solvent; T cell receptor rearrangement

Indexed keywords

ALBICORT; ALPHA2A INTERFERON; CORTICOSTEROID; METHYLPREDNISOLONE; SOLVENT; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LABORATORY TEST; LONG TERM EXPOSURE; MALE; MYCOSIS FUNGOIDES; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; BIOPSY, NEEDLE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON ALFA-2A; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; OCCUPATIONAL EXPOSURE; PAINT; PATCH TESTS; RISK ASSESSMENT; SKIN NEOPLASMS; SOLVENTS; TIME FACTORS;

EID: 1842422625     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076496     Document Type: Article

References (14)

1. Stadler R: Treatment of cutaneous T cell lymphoma. Skin Pharmacol Appl Skin Physiol 2002;15:139-146.
2. Mathur AK, Khanna SK: Dermal toxicity due to industrial chemicals. Skin Pharmacol Appl Skin Physiol 2002;15:147-153.
3. Fischmann AB, Bunn PA Jr, Guccion JG, Matthews MJ, Minna JD: Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sezary syndrome. Cancer Treat Rep 1979;63:591-596.
4. Teixeira F, Ortiz-Plata A, Cortes-Franco R, Dominguez-Soto L: Do environmental factors play any role in the pathogenesis of mycosis fungoides and Sezary syndrome? Int J Dermatol 1994;33:770-772.
5. Morales Suarez-Varela MM, Llopis Gonzalez A, Marquina Vila A, Bell J: Mycosis fungoides: Review of epidemiological observations. Dermatology 2000;201:21-28.
6. Tuyp E, Burgoyne A, Aitchison T, MacKie R: A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987;163:196-200.
7. Whittemore AS, Holly EA, Lee IM, et al: Mycosis fungoides in relation to environmental exposures and immune response: A case-control study. J Natl Cancer Inst 1989;81:1560-1567.
8. Ward MH, Zahm SH, Blair A: Pesticides and cancer risk: Clues from epidemiology studies of farmers and the general population. Pest People Nat 1999;1:25-32.
9. Cohen SR, Kurt SS, Braverman IM, Beck GJ: Mycosis fungoides: Clinicopathological relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980;46:2654-2666.
10. Abel EA: Mycosis fungoides and occupational exposures. Is there an association? Dermatol Clin 1990;8:169-171.
11. Greene MH, Dalager NA, Lamberg SI, Argyropoulos CE, Fraumeni JF Jr: Mycosis fungoides: Epidemiologic observations. Cancer Treat Rep 1979;63:597-606.
12. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas. A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-371.
13. Marzano AV, Borghi A, Facchetti M, Alessi E: Ichthyosiform mycosis fungoides. Dermatology 2002;204:124-129.
14. Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, Arrese Estrada J: Factor XIIIa positive dendritic cells in mycosis fungoides. Cancer J 1992;5:226-229.